Clinical Trial Update: Personalized Risk Stratification Model of Follicular Lymphoma Patients

View source ↗

Summary

A personalized risk stratification model for patients with Follicular Lymphoma is being studied. The trial NCT03436602 is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Snippet

Sponsor: Oncology Institute of Southern Switzerland | Conditions: Follicular Lymphoma | Status: ACTIVE_NOT_RECRUITING